Results 81 to 90 of about 666,379 (164)

Congenital disorder of glycosylation type IIb in an infant with developmental and epileptic encephalopathy. [PDF]

BMJ Case Rep
Shwetabh RK, Singh A, Mandal K, Naranje K, Verma A.   +4 more
europepmc   +1 more source

Molecular Therapeutics in Development to Treat Hyperlipoproteinemia. [PDF]

Mol Diagn Ther
Ahmad M, Hegele RA.
europepmc   +1 more source

Antiarrhythmic Effects of SGLT2 Inhibitors on Supraventricular Tachyarrhythmias in Patients with HFrEF. [PDF]

J Clin Med
Katov L, Rostan J, Teumer Y, Diofano F, Bothner C, Rottbauer W, Weinmann-Emhardt K.   +6 more
europepmc   +1 more source

Malnutrition Modulated Diabetes: A Variant of Type-1 Diabetes or Hybrid Diabetes and Not Type-5 Diabetes'. [PDF]

Indian J Endocrinol Metab
Goswami R, Saha S, Goswami A.
europepmc   +1 more source

Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

Arquivos Brasileiros de Cardiologia
Paulo Eduardo Ballvé Behr, Emilio Hideyuki Moriguchi, Iran Castro, Luiz Carlos Bodanese, Oscar Pereira Dutra, Paulo Ernesto Leães, Pedro Pimentel Filho   +6 more
doaj   +1 more source

An overview of persistent chylomicronemia: much more than meets the eye. [PDF]

Curr Opin Endocrinol Diabetes Obes
Larouche M, Watts GF, Ballantyne C, Gaudet D.   +3 more
europepmc   +1 more source

Serendipitous Discovery of Lipemia Retinalis in a Premature Infant: A Case Report. [PDF]

Case Rep Ophthalmol
Nikkhah H, Karrabi N, Yazdani E, Nezameslami R.   +3 more
europepmc   +1 more source

Can Non-Pharmacological Treatment Promote Additional Benefit for Children with Familial Hypercholesterolemia Treated with Statins?

Arquivos Brasileiros de Cardiologia
Luiza Antoniazzi
doaj   +1 more source

[Treatment of no. II type essential hyperlipoproteinemia with a new therapeutic agent, celluline].

, 1970
Christine Thiffault, M Bélanger, Mylène Pouliot   +2 more
openalex   +1 more source

Rodent Models for Atherosclerosis. [PDF]

Int J Mol Sci
Zeng L, Chi J, Zhu M, Hao H, Long S, Liu Z, Zhang C.   +6 more
europepmc   +1 more source